Thoracic transplantation in 1998.
Thoracic transplantation has been a clinical option for patients with end-stage heart and lung disease for three decades. Heart, lung, and combined heart-lung transplantations are no longer experimental procedures; they are a standard part of the treatment algorithm for selected patients with end-stage heart and lung disease. This article summarizes the current status of heart, lung, and heart-lung transplantations and provides an insight into the future of this field.
Conte
J V
JV
Division of Cardiac Surgery, Johns Hopkins Hospital, USA.
D000075202:Contraindications; D016027:Heart Transplantation / Q000706:statistics & numerical data* / Q000639:trends; D016041:Heart-Lung Transplantation / Q000706:statistics & numerical data* / Q000639:trends; D006801:Humans; D016040:Lung Transplantation / Q000706:statistics & numerical data* / Q000639:trends; D018579:Patient Selection; D015996:Survival Rate